Department of Medicine and Neurology, Melbourne Brain Centre (F.C.N., N.Y., G.S., S.M.D., B.C.V.C.), Royal Melbourne Hospital, University of Melbourne, Parkville, Australia.
Department of Neurology, Austin Health, Heidelberg, Australia (F.C.N.).
Stroke. 2021 Nov;52(11):3450-3458. doi: 10.1161/STROKEAHA.120.033246. Epub 2021 Aug 13.
Whether reperfusion into infarcted tissue exacerbates cerebral edema has treatment implications in patients presenting with extensive irreversible injury. We investigated the effects of endovascular thrombectomy and reperfusion on cerebral edema in patients presenting with radiological evidence of large hemispheric infarction at baseline.
In a systematic review and individual patient-level meta-analysis of 7 randomized controlled trials comparing thrombectomy versus medical therapy in anterior circulation ischemic stroke published between January 1, 2010, and May 31, 2017 (Highly Effective Reperfusion Using Multiple Endovascular Devices collaboration), we analyzed the association between thrombectomy and reperfusion with maximal midline shift (MLS) on follow-up imaging as a measure of the space-occupying effect of cerebral edema in patients with large hemispheric infarction on pretreatment imaging, defined as diffusion-magnetic resonance imaging or computed tomography (CT)-perfusion ischemic core 80 to 300 mL or noncontrast CT-Alberta Stroke Program Early CT Score ≤5. Risk of bias was assessed using the Cochrane tool.
Among 1764 patients, 177 presented with large hemispheric infarction. Thrombectomy and reperfusion were associated with functional improvement (thrombectomy common odds ratio =2.30 [95% CI, 1.32–4.00]; reperfusion common odds ratio =4.73 [95% CI, 1.66–13.52]) but not MLS (thrombectomy β=−0.27 [95% CI, −1.52 to 0.98]; reperfusion β=−0.78 [95% CI, −3.07 to 1.50]) when adjusting for age, National Institutes of Health Stroke Score, glucose, and time-to-follow-up imaging. In an exploratory analysis of patients presenting with core volume >130 mL or CT-Alberta Stroke Program Early CT Score ≤3 (n=76), thrombectomy was associated with greater MLS after adjusting for age and National Institutes of Health Stroke Score (β=2.76 [95% CI, 0.33–5.20]) but not functional improvement (odds ratio, 1.71 [95% CI, 0.24–12.08]).
In patients presenting with large hemispheric infarction, thrombectomy and reperfusion were not associated with MLS, except in the subgroup with very large core volume (>130 mL) in whom thrombectomy was associated with increased MLS due to space-occupying ischemic edema. Mitigating cerebral edema-mediated secondary injury in patients with very large infarcts may further improve outcomes after reperfusion therapies.
对于那些表现出广泛不可逆损伤的患者,再灌注到梗死组织是否会加重脑水肿会影响治疗。我们研究了血管内血栓切除术和再灌注对基线时存在大半球梗死影像学证据的患者脑水肿的影响。
在对 2010 年 1 月 1 日至 2017 年 5 月 31 日发表的 7 项比较血管内血栓切除术与药物治疗前循环缺血性脑卒中的随机对照试验进行系统回顾和个体患者水平荟萃分析(高效再灌注使用多种血管内装置协作)中,我们分析了血栓切除术和再灌注与随访影像学上最大中线移位(MLS)之间的关系,以评估大半球梗死患者脑水肿的占位效应,这些患者在预处理影像学上表现为弥散磁共振成像或 CT 灌注缺血核心 80 至 300 毫升或非对比 CT-阿尔伯塔卒中计划早期 CT 评分≤5。使用 Cochrane 工具评估偏倚风险。
在 1764 名患者中,有 177 名患者表现为大半球梗死。血栓切除术和再灌注与功能改善相关(血栓切除术常见比值比=2.30 [95%置信区间,1.32-4.00];再灌注常见比值比=4.73 [95%置信区间,1.66-13.52]),但与 MLS 无关(血栓切除术β=−0.27 [95%置信区间,−1.52 至 0.98];再灌注β=−0.78 [95%置信区间,−3.07 至 1.50]),但与年龄、国立卫生研究院卒中量表、血糖和随访影像学时间有关。在对核心体积>130 毫升或 CT-阿尔伯塔卒中计划早期 CT 评分≤3(n=76)的患者进行的一项探索性分析中,调整年龄和国立卫生研究院卒中量表后,血栓切除术与更大的 MLS 相关(β=2.76 [95%置信区间,0.33-5.20]),但与功能改善无关(比值比,1.71 [95%置信区间,0.24-12.08])。
在表现为大半球梗死的患者中,血栓切除术和再灌注与 MLS 无关,除非在核心体积非常大(>130 毫升)的亚组中,在该亚组中,由于占位性缺血性水肿,血栓切除术与增加的 MLS 相关。减轻非常大梗死患者的脑水肿介导的继发性损伤可能会进一步改善再灌注治疗后的结局。